These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27465467)
21. Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant. Lu F; Hogenesch H Vaccine; 2013 Aug; 31(37):3979-86. PubMed ID: 23770306 [TBL] [Abstract][Full Text] [Related]
22. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice. Gupta D; Radhakrishnan M; Kurhe Y Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613 [TBL] [Abstract][Full Text] [Related]
23. Subcutaneous nodule after vaccination with an aluminum-containing vaccine. Avcin S; Jazbec J; Jancar J Acta Dermatovenerol Alp Pannonica Adriat; 2008 Dec; 17(4):182-4. PubMed ID: 19104744 [TBL] [Abstract][Full Text] [Related]
24. Suspected side effects to the quadrivalent human papilloma vaccine. Brinth L; Theibel AC; Pors K; Mehlsen J Dan Med J; 2015 Apr; 62(4):A5064. PubMed ID: 25872549 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule. Germar MJ; Purugganan C; Bernardino MS; Cuenca B; Chen YC; Li X; Van Kriekinge G; Lee IH Hum Vaccin Immunother; 2017 May; 13(5):1158-1166. PubMed ID: 28075249 [TBL] [Abstract][Full Text] [Related]
26. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695 [TBL] [Abstract][Full Text] [Related]
27. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347 [TBL] [Abstract][Full Text] [Related]
28. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial. Leung TF; Liu AP; Lim FS; Thollot F; Oh HM; Lee BW; Rombo L; Tan NC; Rouzier R; Friel D; De Muynck B; De Simoni S; Suryakiran P; Hezareh M; Folschweiller N; Thomas F; Struyf F Hum Vaccin Immunother; 2015; 11(7):1689-702. PubMed ID: 26062002 [TBL] [Abstract][Full Text] [Related]
29. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. Young DL; Moore MM; Halstead LA J Voice; 2015 Mar; 29(2):223-9. PubMed ID: 25619468 [TBL] [Abstract][Full Text] [Related]
30. A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. Lin SH; Chou ML; Chen WC; Lai YS; Lu KH; Hao CW; Sheen LY J Ethnopharmacol; 2015 Dec; 175():266-72. PubMed ID: 26408043 [TBL] [Abstract][Full Text] [Related]
31. Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study. Einstein MH; Levin MJ; Chatterjee A; Chakhtoura N; Takacs P; Catteau G; Dessy FJ; Moris P; Lin L; Struyf F; Dubin G; Hum Vaccin Immunother; 2014; 10(12):3455-65. PubMed ID: 25483700 [TBL] [Abstract][Full Text] [Related]
37. Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes. Shaw CA; Li Y; Tomljenovic L J Inorg Biochem; 2013 Nov; 128():237-44. PubMed ID: 23932735 [TBL] [Abstract][Full Text] [Related]
38. A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. Khan FU; Ihsan AU; Nawaz W; Khan MZ; Yang M; Wang G; Liao X; Han L; Zhou X Immunol Lett; 2017 Jul; 187():61-67. PubMed ID: 28526581 [TBL] [Abstract][Full Text] [Related]
39. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Vichnin M; Bonanni P; Klein NP; Garland SM; Block SL; Kjaer SK; Sings HL; Perez G; Haupt RM; Saah AJ; Lievano F; Velicer C; Drury R; Kuter BJ Pediatr Infect Dis J; 2015 Sep; 34(9):983-91. PubMed ID: 26107345 [TBL] [Abstract][Full Text] [Related]
40. Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case. Marsee DK; Williams JM; Velazquez EF Am J Dermatopathol; 2008 Dec; 30(6):622-4. PubMed ID: 19033943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]